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ABSTRACT
Background: In the past decade the issue of patient
mobility has emerged on the European health policy
agenda. Although the volume of patients crossing borders
to obtain healthcare is low, it is increasing continuously
and, due to its legal, financial and medical implications,
has generated considerable interest among health policy
and other decision makers. However, there is little
information available on the safety and patient-centred-
ness of cross-border care and neither governments nor
citizens have an explicit basis for comparing healthcare
delivery in Europe.
Methods: This study investigated the viewpoints of
patients, professionals and healthcare financiers on the
safety and patient-centredness of cross-border care.
Qualitative interviews were carried out during 2005 and
early 2006 with 40 patients, 30 professionals (doctors,
nurses and managers) and 3 healthcare-financing bodies.
Results: Although cross-border care has become a
common issue in many European countries, there remain
uncertainties on the side of each of the parties
addressed—patients, professionals and financiers—with
regard to the provision of cross-border care. One of the
most striking results of this project is the current lack of
research on systematic knowledge on the quality of cross-
border care.
Conclusion: Many of the issues identified through this
research may have a potential impact on the quality and
safety of cross-border care and will support further
investigation and help shape the health policy agenda on
patients crossing borders in European Union countries.
The provision of cross-border care is a phenom-
enon that received considerable policy attention in
past years. In response to this phenomenon, and
considering a range of unresolved legal, financial
and administrative issues, and the implications for
patient care, the European Commission (EC)
financed a number of ‘‘Scientific Support to
Policies’’ (SSP) activities. The research presented
in this paper was conducted within the ‘‘Methods
of Assessing Response to Quality Improvement
Strategies’’ (MARQuIS) Project, one of the EC-
funded SSP projects. The legal framework under
which cross-border care takes place, the general
framework for the SSP policies and an introduction
to the background and objectives of the MARQuIS
Project are presented elsewhere in detail.
12
There are different reasons for patients seeking
or obtaining care in a different country: visitors
abroad who might need of emergency care; retired
people moving as long-term residents to other
countries need the same network of general and
specialist services as local patients but with
different quality requirements; people living in
border areas may cross borders to circumvent
waiting lists; people may be referred abroad for
specialist services; and some people seeking treat-
ment abroad themselves.
3 Each group of patients
may have different expectations, quality require-
ments and a different experience of the care
process.
An extensive literature base exists on assessing
and improving patient safety and patient-centred-
ness of hospital services.
45 In addition, there is
growing literature on the expectations and quality
requirements for groups of patients who have
limited literacy skills, patients who do not speak
the local language, immigrant patients or patients
who differ in their cultural views and expecta-
tions.
6–10
However, knowledge about patient safety and
patient-centredness issues related to patients cross-
ing borders to obtain care has remained rather
scarce until now.
11 Studies have found that there is
remarkably little systematic information on the
volume and scope of cross-border care, and in
particular on the perspectives and outcomes of
cross-border care at the patient level.
12 13 Some
surveys on experiences of cross-border patients
indicate that this group of patients encounters
problems regarding travelling (financially and
logistically), emotional issues associated with dis-
tance from home, unfamiliarity with access proce-
dures and continuity of care.
14
The aim of this study was to assess whether
particular quality requirements exist for this group
of patients. We focused our study on patient-
centredness and safety issues because of their
transversal nature and relevance to cross-border
care. These terms were defined as follows:
‘‘Patient-centredness refers to health care that
establishes a partnership among practitioners,
patients, and their families (when appropriate) to
ensure that decisions respect patients’ wants,
needs, and preferences and that patients have the
education and support they need to make decisions
and participate in their own care’’,
15 while ‘‘patient
safety refers to the prevention of harm caused by
errors of commission and omission’’.
16
Taking into consideration patients’, profes-
sionals’ and healthcare financiers’ experiences, the
research presented in this article led to the
identification of potential safety and patient-
centredness issues for which further research, the
development of instruments and quality improve-
ment actions might be indicated.
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Qualitative interviews were carried out to collect information
on the views of patients, professionals and financiers on the
safety and patient-centredness of cross-border care. For our
study we considered all types of cross-border patient as one
group, although interviews with professionals allowed identifi-
cation of some topics associated with a particular group of
cross-border patients. To guide the identification of issues, we
used a simplified service delivery model reflecting a functional
perspective of hospital services from the patients’ perspective:
17
c ‘‘Patient admission’’ entails information, activities, pro-
cesses and systems that are related to administrative
requirements and access to care for both emergency or
planned admissions.
c ‘‘Diagnosis and intervention’’ comprises all activities related
to direct care and the treatment of patients.
c ‘‘Discharge’’ embraces information and systems related to
the end of the care process at a given location, transfers to
another provider or patient support to go back home.
A semi-structured interview guideline was developed based
on the conceptual model and existing literature on cross-border
care issues, which was revised after carrying out a pilot test
(interview guidelines are available on request from the first
author). Interviews were structured in three phases: introduc-
tion, topic generation and closure.
18 19 The introduction phase
aimed at clarifying the objectives of the interview and
identifying the day-to-day experience the interviewee had with
cross-border care. The topic generation phase aimed at generat-
ing knowledge around the experience of the interviewee with
cross-border care issues. Prompts were used to elicit feedback
when the interviewee found it difficult to respond to a question.
In the closing phase, the main views of the interviewee with
regard to patient safety and centredness issues for cross-border
care were summarised to double-check understanding.
Participants
Due to the relatively low volume of cross-border care, random
sampling would have been unfeasible. Therefore, patients,
professionals and financiers were identified by convenience
sample across seven countries participating in the MARQuIS
project. Recruitment of additional interviewees was stopped
when saturation was reached. For patient interviews, contact
persons in the participating hospitals identified eligible inter-
viewees and obtained informed consent to participate in the
interview, which was carried out shortly before discharge.
Interviews were conducted in five languages. The professionals’
perspective was studied by interviewing managers and health
professionals (doctors and nurses) from facilities with a high
volume of cross-border patients. In each of the study hospitals,
the chief executive officer (CEO) identified a manager, a doctor
and a nurse with experience in delivering cross-border care, for
participation in the study. Professionals’ interviews were
conducted in three languages. For the healthcare financing
perspective, interviews were carried out with representatives
from major European health financing institutions, based in the
Netherlands and in Belgium, with experience in purchasing
cross-border care.
Data collection and analysis
Interviews were held in person (for the patients’ and the
financiers’ perspective) or on the phone (for the professionals’
perspective). Interviews lasted 25–45 min and were recorded
and transcribed. A member of the research team (the main
author) reviewed the interview transcripts and notes for themes
and emergent issues and tagged them manually.
20 In a first step,
the results of the interviews carried out with patients,
professionals and healthcare financing bodies were summarised
independently. In a second step, the views of patients,
professionals and financiers on the safety and patient-centred-
ness of cross-border care were assessed for convergent or
divergent responses. Interviews were carried out during 2005
and early 2006.
RESULTS
Overall, 40 EU patients from 14 countries admitted to 7
different hospitals in Italy and Spain, 30 health professionals
from 14 hospitals in 6 European countries (Belgium, Czech
Republic, Ireland, Poland, Spain and the Netherlands) and
interviewees from 3 healthcare financing bodies (in Belgium and
the Netherlands) participated in this study. We analysed the
safety and patient-centredness issues for cross-border care across
the three groups of interviewees and four transversal themes
emerged from this analysis:
c communication and information issues;
c administrative procedures;
c clinical procedures;
c hotel services and physical environment.
Boxes 1–4 illustrate some of the statements of the interviewees
that led to the identification of themes. Due to the large
amount of information we have not reported all direct
statements of interviewees; instead we have summarised the
main research and improvement topics that we derived from
these statements in appendix A.
Cross-border patients have communication and information
needs at all stages of the care process—admission, diagnosis/
intervention and discharge—and their needs are not limited to
clinical issues but rather address the whole healthcare process as
well as the scheduling of tests and procedures for which
communication is very important. Differences exist in the way
patients collaborate and get involved in decisions about their
own treatment, including the role of the family in different
cultures. Patients found it difficult to identify the different
professional profiles (other than the doctors) and requested
further information in different languages on the hospital and
unit organisation. Professionals confirmed the lack of commu-
nication between providers for cross-border patients—for
example, contacts with the family doctor to validate the history
of the patient, during both the admission and discharge phases
(box 1).
All three groups of interviewees confirmed that adminis-
trative requirements regarding forms E111 and E112 can pose
problems in individual cases, such as when patients do not have
the forms or use them fraudulently. Patients were not worried
about hospitalisation charges; however, financiers and profes-
sionals consider cross-border patients to be more expensive
because of the higher administrative burden and information
requirements. Health financiers mentioned that they would like
to selectively contract with individual providers whereas
professionals think that contracts should be made at the health
system level and not with individual providers.
With regard to the authorisation to obtain elective treatment
abroad, there seem to be cases where free movement of patients
is not fully ensured and interviewees pointed out that eligibility
needs to be assessed more strongly based on recommendations
by specialists, not solely on administrative grounds (box 2).
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needs and to administrative and clinical procedures. In many
cases, informed consent forms are only available in the local
language (due to legislation on medical documentation) while in
others a variety of forms was translated into foreign languages.
The extent of informed consent also varies from a form simply
declaring that the patient agrees with performing a procedure to
a comprehensive patient information package that requires the
patient’s signature. Similar legal issues and differences in scope
relate to the information provided on discharge.
Differences in medical procedures have been found between
countries with regard to transplantation procedures (related to
the use of organs from non-heart-beating patients), quantity of
rehabilitation services or caesarean section on demand (which is
Box 1: Example statements for communication and information issues
‘‘There are a number of difficulties in assessing [cross-border] patients, for example, that the patient does not carry required information/
clinical record, or brings medication that can not be clearly identified so it is difficult to know what to provide. Many patients come alone
and this brings along further difficulties as there is no one to provide answers. There are obvious problems in evaluating symptoms if the
patient does not speak English.’’ (Professional PRO-1)
‘‘[cross-border patients] are usually more critical and have higher information requirements, but in the end they are even more satisfied than
local patients because they compare the care they received with what they would have got in their own country.’’ (Professional PRO-9)
‘‘a pregnant woman … could not speak any language apart from her mother tongue, [she] did not understand what was going on to her, and
the woman not understanding the basic rules of hospitalisation like switching off of mobile phone in the night and visiting hours, this caused
some problems to the other patients in the room’’ (Professional PRO-3)
‘‘Three different interpreters went around the unit asking if there are problems, but they are not there when needed, they are more there to
listen rather than really help. I was not asked what my needs were’’ (Patient ES7-IRL-M-2)
‘‘In the emergency department there was too much chaos, too many people, and I was suffering. I think that there was a ‘privacy problem’
since doors were kept open and everybody passes by … it would be better to keep the doors closed. There is too much noise at the
hospital. It is difficult to speak. Nurses would open the door while they [patients] are sleeping, making a lot of noise.’’ (Patient ES15-F-M-2)
‘‘The reality is that it [good communication] is not ensured; for example, language problems can cause problems in cross-border care. There
are regions where there’s more experience with cross-border care and they work it out in the region. It’s important to discuss cross-border
care at European level, because a lot can be learned from each other.’’ (Financier FIN-2)
Box 2: Example statements for administrative procedures
‘‘Before the patient arrives I have had contact already, they send file, I need to agree, everything is managed before, the patients that are
referred to me never come by hazard. Patients need the E-112, but sometimes the country is reluctant—there is no free movement of
patients. [Movement of patients] should not only be administrative process, there should be recommendations by [the specialist] to provide
surgery’’ (Professional PRO-6)
‘‘Sometimes there may be problems to discharge patients. … Some patients need to stay in a hospital but not in this one and then
sometimes it is difficult to find an ambulance to transport the patient to his country, especially on Fridays.’’ (Professional PRO-1)
‘‘A serious issue is the organisation of back-transfer. We needed to transfer a patient [across the border] and when he arrived [at the
hospital], there was no ICU [intensive care unit] bed available. They brought him back to our hospital, but he died on the way. There is lack
of information systems to check the availability of beds.’’ (Professional PRO-22)
‘‘We always visit hospitals we want to contract to have an impression at least of how the care is in the hospital.’’ (Financier FIN1)
‘‘Now, a special issue for quality of cross-border care is the combination of quality aspects from both the home and the host country …. For
the quality of care abroad you must rely on regulatory bodies or ministries or legal frameworks concerning quality of that country. But the
combination, that may be the problem. Especially in cases where follow-up treatment is given in the home country of the patient.’’ (Financier
FIN3)
‘‘There was miscommunication between the insurance and the hospital, missing faxes, dealing with the paperwork was terrible… I had to
advance the money…’’ (Patient ES16-NL-F-2)
‘‘It is very difficult for the patient to find information on what they have to expect on the other side of the border. There’s no regular
information or regular basis to find this kind of information, no books, brochures on this. We are working on providing patients with good
information, for instance on a … healthcare portal with that information.’’ (Financier FIN3)
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cross-border patients is that discharge date (either too early, or
after excessive length of stay) may be influenced by previously
made travel arrangements, rather than medical criteria.
Patients may also have problems obtaining medication from
local pharmacies, particularly if they have different names or
dosages (box 3). Patients, professionals and financiers confirmed
that cross-border patients make higher demands on a hospital’s
hotel services. The most common requests related to issues such
as timing and size of meals and privacy; other main issues were
respect for families’ or carers’ needs, accommodation, informa-
tion about the patient’s situation and purchasable items.
Professionals pointed out that cultural differences exist in the
way patients from the north, south and east of Europe
collaborated in the care process (box 4).
DISCUSSION
The research base for the quality of cross-border care is currently
not very well developed. Our research helped to identify some
issues related to patient safety and patient-centredness of cross-
border care that may inform further research and quality
improvement activities.
21 In general, although patients express
positive opinions regarding the quality of care they receive
abroad and professionals claim that they treat local and cross-
border patients alike, there are some potential quality and safety
issues for cross-border care, because of the information
requirements and complexity of the care process, especially
when follow-up care is required.
Information and communication issues
Information and communication were the main priorities of
cross-border patients, irrespective of the reason for admission.
These priorities addressed the whole hospitalisation from
admission to discharge. There is substantial literature evidence
that information and communication are integral components
of the care process;
22 23 in fact, full access to healthcare includes
cultural and linguistic access as well as financial access.
24 Some
hospitals employ a range of strategies to address this issue, such
as multilingual reception, written information in various
languages and/or professionals (such as but not limited to
interpreters) speaking various languages. For cross-border
patients, families and carers also play an important role in
ensuring information exchange.
25 Interviews with patients and
professionals also showed that some cultural differences seem to
exist regarding the patients’ expectations and their ability and
willingness to collaborate in the care process: patients from
Box 3: Example statements for clinical issues
‘‘Differences exist in type, name and dosage of drugs; this is a potential patient safety issue.’’ (Professional PRO-5)
‘‘In our hospital we have more than 200 consent forms, depending on the pathology and we considered translating them, but of course, with
so many forms that need to be updated, this is not feasible.’’ (Professional PRO-1)
‘‘In Germany it’s legally arranged: informed consent. In Belgium it’s more like the Dutch situation: the doctor will tell you [verbally] all the
possible complications of the treatment. So an important aspect would be an informed consent written in your own language. That’s not the
case at present. In Germany you get an informed consent written in German.’’ (Financier FIN-2)
‘‘One important example [for differences in clinical procedures] would be transplantation medicine. For kidney transplants the waiting list is
very long, but we have found a way to use kidneys from non-heart-beating patients. Although there are some minor differences in the quality
of the organs, we have achieved some really good results. I have now experienced that it is forbidden in Germany to use organs from non-
heart-beating patients and I have tried to introduce to my German colleagues our experiences. But there was a major reaction: ‘This will
never be done in Germany!’. The response was that this is never going to happen in Germany, there seem to be major cultural differences
with regard to the use of organs from non-heart-beating patients.’’ (Professional PRO-14)
‘‘Many foreign patients set a time limit for the in-patient stay ‘I can stay until Sunday, then I have to take my plane!’. Even if we tell them
that it is not safe, they sometimes insist. There is a form for voluntary discharge to be signed.’’ (Professional PRO-15)
Box 4: Example statements for hotel services and physical structure
‘‘Patients from Nordic countries that are used to quiet environments and everything being in order are sometimes scared when they arrive at
our hospital because everything is much more busy, noisy and does not seem to be so organised to the Nordic patients. Also, the times
when meals are served and our working times are strange to these patients. Patients from other Mediterranean countries are closer to our
culture, for them there is no major difference.’’ (Professional PRO-10)
‘‘The bed was extremely squeaky and with the noise she made she disturbed me. When I asked the doctor for another bed, he said that I
was in a hospital, not in a hotel. The communication is terrible, and food is not nice, and water is not enough, and the smell of the detergent
they use for personal care is unpleasant’’ (Patient ES2-D-F-2)
‘‘When he [the husband] arrived at the hospital he had to be reanimated. They put me in a waiting room and did not provide any information.
I did not know what was going on. Only after everything was over someone informed me about what had happened. When the emergency
was over, the hospital called the hotel and even British Airways.’’ (Patient ES17-UK-M-1)
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others were considered to be more passive in the care process.
26
The discharge and follow-up phases appear to be among the
weakest points in the cross-border care process. Ensuring
continuity of care will remain a challenge in the absence of
common requirements for hospitals in Europe concerning the
type and timeliness of information provided on discharge to the
patient and to health services providers. All groups of
interviewees confirmed this issue, which is also supported by
the findings of a parallel study.
27
Administrative procedures
For patients who intentionally travel to another country to
obtain care, a clear understanding of administrative procedures
is a prerequisite to making an informed decision. Given the fact
that cross-border care is a growing phenomenon in Europe,
12 8
the lack of information sources on treatment in different
European countries is worth highlighting. On the other hand,
patients who unexpectedly need treatment while abroad
commonly face the problem of not having the needed
documentation and not being familiar with bureaucratic
procedures. As a result, patients get hospitalised without the
E111 form, which they usually apply for only once they are at
the hospital. This bureaucratic problem can cause unnecessary
delays in care. In particular, patients with chronic health
conditions, and those with recurrent acute health problems,
who plan to travel should be provided with relevant informa-
tion about their disease or condition, to avoid repetition of tests
and dangerous or unnecessary delays.
Clinical procedures
There appears to be wide discrepancies among European Union
(EU) member states regarding the process of providing informed
consent. Even if some countries have translated the forms into
some EU languages, they are often not translated into all the
needed languages and there is no systematic procedure for
informing patients. This has implications, in particular, for the
comprehensive informed consent procedures required for
clinical trials, as the lack of forms for providing informed
consent in different languages currently makes it difficult to
include cross-border patients.
We also identified potential safety issues with regard to
discharge date and back transfer (in particular with regard to
contracting ambulances to travel to a different country or
arranging a hospital bed in another country). Other safety issues
involve quarantine procedures for methicillin-resistant
Staphylococcus aureus (MRSA).
27 Another potential patient safety
issue is related to drug use, as drugs may be prescribed and/or
administered that have different names or dosages in other
countries. Common requirements for information provided at
discharge and generic name prescribing may improve cross-
border care. However, the development of integrated care
networks even faces challenges when professional and organisa-
tional boundaries within countries need to be crossed, and
standardisation of criteria, protocols and rules cannot substitute
for direct contact to share information and knowledge.
29
Physical structure and hotel services
Regarding hotel services, there are indications that cross-border
patients have higher demands, mostly related to privacy and the
possibility of purchasing needed items. Cultural differences in
family involvement (among other aspects) may pose further
challenges to hospital organisation, and hospitals providing
cross-border care for elective procedures may need to assess how
to accommodate patients and families before and during
admission.
Limitations of the research
It needs to be emphasised that the legal framework under which
cross-border care is provided may have implications for
administrative and quality requirements. For example, countries
with bilateral contracts may have arrangements in place to
regulate volume, tariffs, procedures, quality and non-medical
aspects of hospital care, and may hence avoid some of the issues
related to cross-border care provision identified in this research.
Thus, the exploratory nature of this research deserves particular
emphasis given different contexts of cross-border care provision.
From a methodological perspective a number of limitations
need to be stressed. First, interviewees were recruited through
convenience sampling in order to include as much variation as
possible. Only two Mediterranean countries participated in the
interview arm of the study—one of them a major exporter of
patients (Italy) and another a major receptor (Spain). However,
views were collected for patients from 14 countries. Healthcare
professionals were recruited from hospitals known to deliver
cross-border care. The interviews with healthcare financiers
were conducted with two financing bodies in Belgium and the
Netherlands, with one interviewee representing an umbrella
organisation of healthcare-financing bodies. While this sampling
method can be criticised and is likely to have induced significant
bias, it should be kept in mind that random sampling would not
have been feasible due to the low frequency of cross-border care.
Thus the results of this research should not be misunderstood to
convey a generalisable picture of cross-border care provision.
Rather, the strength of this research is that, given the current
dearth of information on quality requirements for cross-border
care, the topics identified here complement existing country
reports,
12 and may guide and prioritise further research on this
topic. This is of particular relevance, given the recent publica-
tion of a proposal for a European directive on the rights of cross-
border patients, and given a recent report highlighting the
heterogeneity with which quality strategies are adopted in the
EU member states.
30 31
CONCLUSION
This research project obtained information on the viewpoints
and priorities of patients, professionals and healthcare-financing
bodies regarding the use of healthcare abroad. The information
derived from the interviews allowed us to identify many quality
Key messages: How this paper links to better patient care
This study identified a range of issues that potentially impact on
the quality and safety of cross-border care. While quality
requirements for cross-border care are similar to those of local
patients, certain situations exist that require particular attention to
the needs of cross-border patients. These situations involve, for
example: communication problems related to history taking and
informed consent; medication safety at discharge due to
differences in type and dosage of drugs; ensuring continuity of
care after discharge due to lack of information provision to
patients and subsequent healthcare providers; and difficulties in
arranging medical back transfer of patients across borders.
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tion and communication, with a potential impact on the quality
and safety of cross-border care. Although quality requirements
for cross-border care are similar to those of local patients, certain
situations exist that require particular attention to the needs of
cross-border patients. The findings presented here may help to
support further research on patients who cross borders in EU
countries, as expressed in the EU Programme of Community
Action in the Field of Health (2007–2013) and the recent call for
research proposals in this field. It is hoped that our findings will
also help to guide future work on developing quality improve-
ment strategies at EU level.
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APPENDIX A
Topics for further research and quality improvement of cross-
border care
Perceptions of and information on cross-border care
c What is the perception of patients/citizens about the administrative and financial
procedures to obtain cross-border care?
c What is the perception of patients/citizens about the quality of care provided in
other EU countries?
c What health systems and hospital information do patients have access to before
going abroad for treatment? How does this impact on their willingness to obtain
treatment abroad, in particular if cross-border care is offered or recommended by
the purchaser?
c Do governments, purchasers and patients use different criteria when selecting/
contracting a cross-border care provider?
Admission of cross-border patients
c Who checks eligibility for treatment when a foreign EU patient arrives at the
hospital? Is this the sole responsibility of hospital administration, or does
professional or medical judgement play a role?
c What is the impact of cross-border care provision on the administrative burden of
the receiving hospital? Do additional administrative and information requirements
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with in administering cross-border patients?
c For planned admissions, what is the patients’ role and duty to present information
on the course of the condition (tests, medical record)?
Information and communication during the hospital stay
c Once admitted, how do cross-border patients perceive the hospital stay: do they
receive information about what is happening to them, and information on
scheduled visits and tests? How are their language barriers taken into account?
c Are the strategies used by hospitals to overcome language barriers (such as
interpreters or multilingual staff) sufficient to ensure the same level of informed
consent, patient information and education for both local and cross-border
patients? Are they sufficient to ensure that patients feel that their needs are
taken care of, that they are well understood, and that they have an opportunity to
discuss their concerns?
c How are differences in informed consent procedures dealt with? How could
different legal requirements and patients’ needs be harmonised?
c Are there differences in the way patients from different countries contribute to
and collaborate in the care process (expressing themselves, confidence and
anxiety)?
c What is the role of cross-border patients’ families and third parties (interpreters,
hospital staff speaking foreign languages, case managers, embassies) in the care
process?
c How can the hospital meet the catering needs of cross-border patients, given
differences in timing and size of meals between countries?
Discharge, transfer and follow-up
c What are the effects of previously arranged travel on the length of stay and
discharge date of cross-border patients?
c What is the impact of the discharge of cross-border patients on continuity of
care? How are different information and legal requirements, language needs and
transfers to different types of providers in different countries dealt with?
c Are there any quality and patient safety issues resulting from differencesi n
national and foreign regulations for the quality of care (eg, in the case of
transplantation medicine or rehabilitation services)?
c How can patient safety be ensured when providing patients with medication that
differs in name, type and doses between countries?
c What are the administrative requirements for arranging medical back-transfer
across borders? What are the implications (responsibilities and liabilities) in case
of adverse events that occur during medical transport?
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